SCHEMBL303946

SCHEMBL303946

NCCOCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3822077 0.97
SCHEMBL2928001 0.97
SCHEMBL13599228 0.95 TSHR (0.42)
SCHEMBL26111100 0.95 TSHR (0.42)
SCHEMBL60430 0.95 TSHR (0.42)
SCHEMBL28386959 0.95 TSHR (0.42)
SCHEMBL1170690 0.95 TSHR (0.42)
SCHEMBL164253 0.95 TSHR (0.42)
SCHEMBL22806980 0.95 TSHR (0.42)
SCHEMBL1594769 0.95 TSHR (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250381277-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS DANA FARBER CANCER INST INC (US) 2025-12-18 US claimed
US-12435170-B2 Terpolymer and polymer brushes for use against non-specific adsorption of substances from biological media FYZIKALNI USTAV AV CR, V.V.I. (CZ) 2025-10-07 US claimed
EP-4598585-A1 PRODUCT Oxford University Innovation Limited (GB) 2025-08-13 EP claimed
US-12351573-B2 Compounds for use in synthesis of peptidomimetics THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2025-07-08 US claimed
WO-2025136225-A1 PROBES NATIONAL UNIVERSITY OF SINGAPORE (SG) 2025-06-26 WO claimed
US-12320815-B2 Compositions and methods for enrichment and detection of ubiquitin and ubiquitin conjugates YALE UNIVERSITY (US) 2025-06-03 US claimed
CN-120058903-A Protein tyrosine-tyrosine analogues and methods of use thereof 伊莱利利公司 2025-05-30 CN claimed
CN-112888705-B Protein tyrosine-tyrosine analogues and methods of use thereof 伊莱利利公司 2025-03-11 CN claimed
CN-119212728-A Compositions and methods for treating neurological disorders 丹娜-法伯癌症研究院 2024-12-27 CN claimed
EP-4472670-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS Dana-Farber Cancer Institute, Inc. (US) 2024-12-11 EP claimed
WO-2005012346-A1 LONG LASTING INSULIN DERIVATIVES AND METHODS THEREOF CONJUCHEM, INC. (CA) 2005-02-10 WO claimed
EP-1177209-B1 COMPOSITIONS OF SOLVENTS AND HIGH CONCENTRATIONS OF NUCLEIC ACID ANALOGS APPLERA CORP (US) 2003-10-22 EP claimed
US-6627772-B2 Preparation of N-[2-(carboxymethoxy) ethyl]-N-(carboxymethyl) glycine THE DOW CHEMICAL COMPANY 2003-09-30 US claimed
US-20020192773-A1 Methods for preparation of macrocyclic molecules and macrocyclic molecules prepared thereby THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2002-12-19 US claimed
US-20020147360-A1 Intermediates for the preparation of N-[2-(carboxymethoxy) ethyl]-N-(carboxymethyl) glycine ATHEY PHILLIP S (US) 2002-10-10 US claimed
US-20020010367-A1 Intermediates for the preparation of N-[2-(carboxymethoxy) ethyl]-N-(carboxymethyl) glycine ATHEY PHILLIP S (US) 2002-01-24 US claimed
US-6331618-B1 FOR ANALYTICAL METHODS SUCH AS GEL ELECTROPHORESIS, HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, PRIMER EXTENSION REACTIONS, POLYMERASE CHAIN REACTION (PCR), MASS SPECTROSCOPY, NUCLEAR MAGNETIC RESONANCE (NMR) AND X-RAY CRYSTALLIZATION PE CORPORATION (NY) 2001-12-18 US claimed
WO-2000076959-A2 INTERMEDIATES FOR THE PREPARATION OF (N)-[2-(CARBOXYMETHOXY) ETHYL]-(N)-(CARBOXYMETHYL) GLYCINE THE DOW CHEMICAL COMPANY (US) 2000-12-21 WO claimed
CN-1010941-B Herbicide product containing new salt of dicamba and preparation method thereof SANDOZ LTD (CH) 1990-12-26 CN claimed
CN-85108616-A Contain weedicide product of the new salt of dicamba 98 and preparation method thereof 1987-04-15 CN claimed